Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2026)
Ginkgo Bioworks Holdings posted quarterly Treasury Shares of $1.4 million for Q1 2026, down 66.51% year-on-year from $4.1 million in Q1 2025, and down 68.72% on a QoQ basis from $4.4 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 8 years of Treasury Shares data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 66.51% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 66.51% YoY), and the FY2025 full-year result was $4.4 million, up 697.76% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.4 million, down from $4.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $238.7 million in Q1 2024 and bottomed at $552457.0 in Q4 2024.
- The 5-year median for Treasury Shares is $5.0 million (2025), against an average of $59.7 million.
- Peak annual rise in Treasury Shares reached 697.76% in 2025, while the deepest fall reached 98.28% in 2025.
- A 5-year view of Treasury Shares shows it stood at $134.4 million in 2022, then plunged by 97.17% to $3.8 million in 2023, then tumbled by 85.48% to $552457.0 in 2024, then surged by 697.76% to $4.4 million in 2025, then sank by 68.72% to $1.4 million in 2026.
- The last three Treasury Shares figures came in at $1.4 million (Q1 2026), $4.4 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 552,457.00 |
| Dec 31, 2024 | 552,457.00 |
| Sep 30, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 22.39 Mn |
| Jun 30, 2024 | 22.39 Mn |
| Mar 31, 2024 | 238.71 Mn |
| Mar 31, 2024 | 238.71 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Sep 30, 2023 | 22.79 Mn |
| Sep 30, 2023 | 22.79 Mn |
| Dec 31, 2022 | 134.44 Mn |
| Dec 31, 2022 | 134.44 Mn |
| Sep 30, 2022 | 26.87 Mn |
| Sep 30, 2022 | 26.87 Mn |
| Jun 30, 2022 | 214.27 Mn |
| Jun 30, 2022 | 214.27 Mn |
| Mar 31, 2022 | 211.54 Mn |
| Mar 31, 2022 | 211.54 Mn |
| Dec 31, 2021 | 168.32 Mn |
| Dec 31, 2021 | 168.32 Mn |
| Sep 30, 2021 | 254.25 Mn |
| Sep 30, 2021 | 254.25 Mn |
| Dec 31, 2020 | 124.93 Mn |
| Dec 31, 2020 | 124.93 Mn |
| Dec 31, 2019 | 490,805.00 |
| Dec 31, 2019 | 490,805.00 |